Providing stock analysis for investors of the Canadian junior markets
Cytophage Technologies (TSXV: CYTO) has officially launched trials with one of the largest poultry hatcheries in Canada. The trial will see Cytophage’s OvaPhage product used to target harmful bacteria on the surface of eggs.
Read more
Novo Nordisk witnessed a significant uptick in its share price during European trading on Friday following the announcement of promising
Read more
MustGrow Biologics (TSXV: MGRO) has completed the previously announced acquisition of NexusBioAg from Univar Solutions Canada. Classified as an asset
Read more
Cardiol Therapeutics (TSX: CRDL) has seen a series of insider buys made in recent days, which follows the company seeing success under phase two trials announced in November. A total of four insiders have been in the market this week buying shares, including the firms chief executive, as well as its chief financial officer.
Read more
Cytophage Technologies (TSXV: CYTO) announced a landmark agreement this morning that will see the establishment of Manitoba’s first Phage Clinical Treatment Program. The program will aim to offer new options for patients to manage antibiotic-resistant infections.
Read more
Cassava Sciences, Inc. (NASDAQ: SAVA) witnessed a dramatic over 85% plunge in its stock price following the release of disappointing
Read more
In this interview with David Elsley, President and CEO of Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL), we explore the company’s innovative approach to treating inflammatory heart conditions.
Read more
Cardiol Therapeutics (TSX: CRDL) has seen success under a phase II trial conducted on CardiolRx, which is the company’s lead small molecule drug candidate. The drug is currently going through clinical trials for use in the treatment of heart disease, specifically recurrent pericarditis and acute myocarditis.
Read more
In this interview, Dr. Steven Theriault, CEO & Chief Science Officer of Cytophage Technologies (TSXV: CYTO), discusses the company’s innovative approach to addressing bacterial infections through bacteriophage technology.
Read more
President-elect Donald Trump on Thursday announced that Robert F. Kennedy Jr. would be nominated as the Secretary of the Department
Read more